Reproducibility of dopamine synthesis capacity measured with [11C]DOPA and dopamine transporter binding measured with [18F]FE-PE2I using positron emission tomography

Reproducibility of dopamine synthesis capacity measured with [11C]DOPA and dopamine transporter binding measured with [18F]FE-PE2I using positron emission tomography - Reproducibility of [11C]DOPA uptake and [18F]FE-PE2I binding

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005255

Enrollment

Registered

2011-04-01

Start date

2011-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy male adults

Interventions

Intravenous injection of [11C]DOPA and [18F]FE-PE2I for positron emission tomography.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy male subjects who have the ability to provide informed consent

Exclusion criteria

Exclusion criteria: -Psychiatric disorders including drug dependence -Serious medical illness

Design outcomes

Primary

Measure	Time frame
Intra-subject variations of dopamine transporter binding	—

Secondary

Measure	Time frame
Intra-subject variations of dopamine synthesis capacity	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026